Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.10 -0.10 (-3.13%)
At close: Oct 22, 2026 · 4:00 PM EDT

Apimeds Pharmaceuticals US (APUS) Return on Capital Employed [ROCE] (2025 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) recorded Return on Capital Employed [ROCE] of -14.28% in Q2 2026, up 64.16 percentage points from -78.44% a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Return on Capital Employed [ROCE] (2025 - 2026) Analysis & Trends

For FY2025, Apimeds Pharmaceuticals US reported Return on Capital Employed [ROCE] of -16.69%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 17.52%
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 17.92%
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 6.28%
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 19.32%
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 16.76%
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -5.97%
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 11.86%
10 Apimeds Pharmaceuticals US 5.33 Mn -14.31 Mn - -14.28%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.28%
Dec 31, 2025 -15.67%
Sep 30, 2025 -58.44%
Jun 30, 2025 -78.44%
API Access

Apimeds Pharmaceuticals US Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=APUS&period=max&api_key=YOUR_API_KEY